Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 871 AL 885

Targeting mitochondria for neuroprotection in Parkinson disease

Schapira AH, Patel S.

JAMA Neurol. 2014 May;71(5):537-8. doi: 10.1001/jamaneurol.2014.64.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit

Parkinson Study Group QE3 Investigators; Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, et al.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

Oxidative stress regulation by DJ-1 in the retinal pigment epithelium

Bonilha VL, Rayborn ME, Yang X, Xie C, Cai H.

Adv Exp Med Biol. 2014;801:649-54. doi: 10.1007/978-1-4614-3209-8_81.

Mortality from Alzheimer's disease, Parkinson's disease, and dementias in France and Italy: a comparison using the multiple cause-of-death approach

Désesquelles A, Demuru E, Salvatore MA, Pappagallo M, Frova L, Meslé F, Egidi V.

J Aging Health. 2014 Mar;26(2):283-315. doi: 10.1177/0898264313514443.

Development of targeted therapies for Parkinson's disease and related synucleinopathies

Sybertz E, Krainc D.

J Lipid Res. 2014 Oct;55(10):1996-2003. doi: 10.1194/jlr.R047381. Epub 2014 Mar 25.

Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?

Romero-Ramos M, von Euler Chelpin M, Sanchez-Guajardo V.

Hum Vaccin Immunother. 2014;10(4):852-67. doi: 10.4161/hv.28578. Epub 2014 Mar 26.

Disease severity affects obstacle crossing in people with Parkinson's disease

Vitório R, Lirani-Silva E, Baptista AM, Barbieri FA, dos Santos PC, Teixeira-Arroyo C, Gobbi LT.

Gait Posture. 2014;40(1):266-9. doi: 10.1016/j.gaitpost.2014.03.003. Epub 2014 Mar 12.

Coffee: biochemistry and potential impact on health

Ludwig IA, Clifford MN, Lean ME, Ashihara H, Crozier A.

Food Funct. 2014 Aug;5(8):1695-717. doi: 10.1039/c4fo00042k.

Using the satisfaction with life scale in people with Parkinson's disease: a validation study in different European countries

Lucas-Carrasco R, Den Oudsten BL, Eser E, Power MJ.

ScientificWorldJournal. 2014 Feb 2;2014:680659. doi: 10.1155/2014/680659. eCollection 2014.

Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease

Miguelez C, Morera-Herreras T, Torrecilla M, Ruiz-Ortega JA, Ugedo L.

Front Neural Circuits. 2014 Mar 17;8:21. doi: 10.3389/fncir.2014.00021. eCollection 2014.

The Michelin red guide of the brain: role of dopamine in goal-oriented navigation

Retailleau A, Boraud T.

Front Syst Neurosci. 2014 Mar 18;8:32. doi: 10.3389/fnsys.2014.00032. eCollection 2014.

Meta-analysis: overweight, obesity, and Parkinson's disease

Chen J, Guan Z, Wang L, Song G, Ma B, Wang Y.

Int J Endocrinol. 2014;2014:203930. doi: 10.1155/2014/203930. Epub 2014 Feb 5.

Copper and copper proteins in Parkinson's disease

Montes S, Rivera-Mancia S, Diaz-Ruiz A, Tristan-Lopez L, Rios C.

Oxid Med Cell Longev. 2014;2014:147251. doi: 10.1155/2014/147251. Epub 2014 Jan 8.

Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant

Perez-Lloret S, Merello M.

Expert Opin Pharmacother. 2014 Jun;15(8):1097-107. doi: 10.1517/14656566.2014.903924. Epub 2014 Mar 27.

Breakdown in REM sleep circuitry underlies REM sleep behavior disorder

Peever J, Luppi PH, Montplaisir J.

Trends Neurosci. 2014 May;37(5):279-88. doi: 10.1016/j.tins.2014.02.009. Epub 2014 Mar 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias